NEUP

Neuphoria Therapeutics Inc. (NEUP) ESG Analysis Analysis (2026)

Invetso Score: 5.2/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 4.5 (Moderate)

Neuphoria’s current environmental risk profile is moderate due to its R&D focus and limited operational footprint, but the lack of formal sustainability commitments or disclosures is a notable gap relative to sector best practices.

Social

Score:

Neuphoria demonstrates responsible clinical conduct and transparent investor communications, but lacks disclosure on workforce and community practices, limiting its social ESG profile relative to peers.

Governance

Score:

Governance is moderately strong, with a skilled board and transparent processes, but the presence of activist shareholders and the use of a rights plan highlight ongoing risks and the need for careful alignment of interests.

Overall Score

Score:

Neuphoria Therapeutics’ ESG profile is moderate across all pillars. The company’s limited operational footprint and responsible clinical practices are offset by a lack of formal ESG disclosures and ongoing governance challenges related to strategic uncertainty and activist involvement. While the board’s expertise and transparent communication are positives, the absence of robust environmental and social frameworks constrains its ESG standing relative to leading biotech peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Neuphoria Therapeutics Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →

Invetso is not affiliated with or regulated by the U.S. Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), or any other financial regulatory authority. The analyses, scores and all the information provided by Invetso are strictly for informational purposes only and do not constitute financial advice, recommendations, or an offer to buy or sell any securities. Invetso is not a registered financial advisor, broker-dealer, or investment advisor, and it does not provide personalized investment, legal, or tax advice. The content provided on this website is not intended to serve as a substitute for professional advice. Users should conduct their own research and consult with a qualified financial advisor before making any investment decisions. All analysis, data, and information presented on this site are based on publicly available information and should be used at the user’s own risk. Invetso does not guarantee the accuracy, completeness, or timeliness of any information or data provided, nor does it endorse any specific securities, companies, or strategies. Any reliance you place on such information is strictly at your own risk. While we strive to provide accurate and up-to-date information, Invetso makes no warranties or representations regarding the completeness, accuracy, or reliability of any analyses or data on our platform, and any such information is subject to the terms and conditions of the Invetso Terms of Service. Our analyses are generated using AI technologies and AI-generated content may contain errors or inaccuracies. Use the information at your own risk. Our platform may contain links to third-party websites, for which we are not responsible for the content or accuracy of information. Invetso shall not be liable for any loss or damage arising from the use of our services. By using this website, you agree that Invetso is not responsible for any losses, damages, or financial outcomes that may result from your use of the information, tools, or resources provided. We recommend consulting with a licensed financial professional before making any investment decisions.

For more details, please refer to our Terms of Service and Privacy Policy.